Piramal Enterprise appoints Anita Marangoly George as Independent Director
Mumbai: Piramal Enterprise has recently announced the appointment of Anita Marangoly George as an Additional Director of the Company with effect from 10th February, 2022 to hold office as Independent Director of the Company for a term of 5 years, subject to the approval of the shareholders.
"George is not related to any of the Directors of the Company," the company said in a BSE filing.
Anita Marangoly George is a distinguished financial sector executive with extensive and diverse global experience in institutional finance and investing in sustainable infrastructure in Renewable Energy, Logistics and Water. She commands deep expertise in finance, including credit, structured finance, project finance, mezzanine and equity investments. She has a good understanding of the loan book (wholesale and retail), housing and real estate finance, advisory businesses including mandatory pension, wealth management, asset reconstruction and stressed debt.
George is well known in the industry for her expertise in Infrastructure finance especially Renewable Energy Finance and Climate Finance. She was part of the team responsible for created the Scaling Solar initiative at the World Bank Group. At the International Finance Corporation ('IFC'), she created a new business line for municipal finance and pioneered IFC's investments in the Renewable Energy Sector. At Caisse de Dépôt et Placement du Québec ('CDPQ') she grew the emerging markets exposure from 5% to 15% during her five year tenor and was Executive Vice President and Deputy Head of CDPQ Global.
She is passionate about and committed to human capital development and economic empowerment of women and girls. She is actively engaged in mentoring women and girls.
George holds a dual master's degree in Economic Policy and a Master of Business Administration in Finance from Boston University, and a Bachelor of Arts in Economics with a minor in Spanish from Smith College.
Read also: Piramal Pharma Solutions expands, upgrades UK facilities
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.